4.7 Article

Bioluminescence imaging of Hepatitis C virus NS3/4A serine protease activity in cells and living animals

期刊

ANTIVIRAL RESEARCH
卷 87, 期 1, 页码 50-56

出版社

ELSEVIER
DOI: 10.1016/j.antiviral.2010.04.010

关键词

NS3/4A protease; Split firefly luciferase complementation strategy; In vivo imaging

资金

  1. Natural Science Foundation of China [30600330, 30671842, 30672488, 30700475, 30771919, 30700757]
  2. National High Technology Research and Development Program of China [2008AA02Z132]
  3. Beijing, Municipal Natural Science Foundation [5082016]
  4. Mega-projects of Science Research for the 11th Five-Year Plan [2009ZX10004-4001]

向作者/读者索取更多资源

The lack of robust small animal models has been an obstacle to the screening of Hepatitis C virus (HCV) NS3/4A protease inhibitors in vivo. Here, we described a reporter assay system for in vivo noninvasive imaging of NS3/4A serine protease activity using split firefly luciferase complementation strategy. The reporter construct ANIuc(NS5A/B)BCluc constitutes the split N- and C-terminal fragments of luciferase, fused to interacting peptides, pepA and pepB, respectively, with an intervening HCV NS3/4A cleavage motif of NSSA/B. we proved that the reporter molecule could be proteolytically cleaved by NS3/4A at the NS5A/B motif in cells and living animals. Association of pepA and pepB brought inactive fragments of luciferase into close proximity, thereby restoring bioluminescence activity. The increase in luciferase activity was proportional to the dose of active NS3/4A protease. The ANIuc(NS5A/B)BCluc reporter also could be used to detect the activity of NS3/4A-specific shRNA and IFN-alpha. Therefore, the reporter assay system using split firefly luciferase complementation strategy should prove useful for evaluating NS3/4A protease activity in cells and living animals. (C) 2010 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据